BRISTOL MYERS SQUIBB

bristol-myers-squibb-logo

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

#SimilarOrganizations #People #Financial #Event #Website #More

BRISTOL MYERS SQUIBB

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1970

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.bms.com

Total Employee:
10001+

Status:
Active

Contact:
(212)546-4000

Total Funding:
6.08 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Nginx


Revenue:
46.16 B
Total Assets:
96.82 B
Total Cash:
9.12 B

Similar Organizations

accendowave-logo

AccendoWave

AccendoWave provides discomfort detection, monitoring, and reporting devices for the reduction of human suffering.

amerisourcebergen-logo

AmerisourceBergen

AmerisourceBergen provides pharmaceutical supply chain distribution & pharmacy management solutions.

bartell-drugs-logo

Bartell Drugs

Bartell Drugs is the oldest family owned drugstore chain in the USA.

dohmen-life-science-service-logo

Dohmen Life Science Service

Intelligent outsourcing for drug and device manufacturers.

eli-lilly-logo

Eli Lilly

Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.

g-d-searle-logo

G. D. Searle

G. D. Searle, LLC is a research-based pharmaceutical company that manufactures and markets prescription pharmaceuticals and other

gilead-science-korea-logo

Gilead Science Korea

Gilead Science Korea is engaged in medical, licensing, marketing, and sales activities.

gilead-sciences-logo

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

johnson-johnson-logo

Johnson & Johnson

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.

knmp-logo

KNMP

KNMP is the Royal Dutch Society for the Promotion of Pharmacy is the umbrella professional and branch organization of pharmacists.

laboratoires-genevrier-logo

Laboratoires Genevrier

Laboratoires Genevrier engages in improving human health by offering an extensive range of innovative and effective pharmaceutical products.

mayinglong-logo

Mayinglong

Mayinglong Pharmaceutical Group manufactures and markets pharmaceutical products.

medical-products-laboratories-logo

Medical Products Laboratories

Medical Products is into research, development, manufacturing and distribution of innovative products to our customers.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

ono-pharmaceutical-logo

ONO Pharmaceutical

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.

orajel-logo

Orajel

Orajel engages in the manufacture and marketing of cosmetics and over-the-counter pharmaceuticals.

pfizer-logo

Pfizer

Pfizer provides access to safe and effective and affordable medicines and health care services.

not_available_image

Pleasant Valley Fund

Pleasant Valley Fund LLC is an early and seed stage investment fund focused on mobile, data, health, biomedical and pharma verticals.

roxane-laboratories-logo

Roxane Laboratories

Roxane Laboratories engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals.

shionogi-logo

Shionogi

Shionogi supply the best possible medicine to protect the health and wellbeing of the patients they serve.

sustained-nano-systems-logo

Sustained Nano Systems

Sustained Nano Systems is a company that offers short or long-term micro-dosing for targeting the cell for several therapeutics purposes.

syndel-logo

Syndel

For more than 40 years, Syndel has been a leader in developing high quality aquaculture pharmaceutical health and nutritional products.

teva-pharmaceutical-industries-logo

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.

university-of-california-san-francisco-logo

University of California, San Francisco

Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine

walgreens-logo

Walgreens

Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.

wepa-apothekenbedarf-gmbh-co-kg-logo

WEPA APOTHEKENBEDARF GmbH & Co KG

WEPA APOTHEKENBEDARF GmbH & Co KG distributes healthcare, laboratory, and formulation equipment and products for pharmacies.

yliopiston-apteekki-logo

Yliopiston Apteekki

Yliopiston Apteekki is an online store that offers a wide range of medicine, cosmetics, vitamins and nutritional supplements.


Current Advisors List

giovanni-caforio_image

Giovanni Caforio Chairman @ Bristol Myers Squibb
Board_member
2017-05-01

vicki-sato_image

Vicki Sato Member of the Board of Directors @ Bristol Myers Squibb
Board_member

lewis-campbell_image

Lewis Campbell Board of Directors @ Bristol Myers Squibb
Board_member

laurie-glimcher_image

Laurie Glimcher Board of Directors @ Bristol Myers Squibb
Board_member

gerald-storch_image

Gerald Storch Board of Directors @ Bristol Myers Squibb
Board_member

lamberto-andreotti_image

Lamberto Andreotti Chairman of the Board @ Bristol Myers Squibb
Board_member

thomas-lynch_image

Thomas Lynch Member of the Board of Directors @ Bristol Myers Squibb
Board_member

michael-grobstein_image

Michael Grobstein Board of Directors @ Bristol Myers Squibb
Board_member

Current Employees Featured

john-damonti_image

John damonti
John damonti Foundation President @ Bristol Myers Squibb
Foundation President
1991-09-01

sandra-leung_image

Sandra Leung
Sandra Leung Senior Vice President, General Counsel & Secretary @ Bristol Myers Squibb
Senior Vice President, General Counsel & Secretary
2007-02-01

chris-boerner_image

Chris Boerner
Chris Boerner Executive Vice President, Chief Commercialization Officer @ Bristol Myers Squibb
Executive Vice President, Chief Commercialization Officer
2018-07-01

mita-maity_image

Mita Maity
Mita Maity Research Scientist @ Bristol Myers Squibb
Research Scientist
2011-11-01

douglas-kou_image

Douglas Kou
Douglas Kou Co-Chair Observational Protocol Review Committee @ Bristol Myers Squibb
Co-Chair Observational Protocol Review Committee
2012-07-01

frédéric-baribaud_image

Frédéric Baribaud
Frédéric Baribaud Academic Research Collaboration Lead @ Bristol Myers Squibb
Academic Research Collaboration Lead
2021-04-01

hommy-almonte_image

Hommy Almonte
Hommy Almonte Immuno-Oncology Field Sales Trainer @ Bristol Myers Squibb
Immuno-Oncology Field Sales Trainer
2019-01-01

doug-bassett_image

Doug Bassett
Doug Bassett SVP Informatics & Predictive Sciences @ Bristol Myers Squibb
SVP Informatics & Predictive Sciences
2019-11-01

debra-boyko-debrito_image

Debra Boyko-DeBrito
Debra Boyko-DeBrito Director Content Management Solutions @ Bristol Myers Squibb
Director Content Management Solutions
1986-09-01

jennifer-klesh_image

Jennifer Klesh
Jennifer Klesh Associate Director @ Bristol Myers Squibb
Associate Director
2018-11-01

Founder


john-ripley-myers_image

John Ripley Myers

william-mclaren-bristol_image

William McLaren Bristol

Stock Details


Company's stock symbol is BMY. Lastest price : 64.44$. Total volume :5.64M Click reload if you want to check the lastest price on market!!!
Exchange NYSE. Currency in USD. Market state POST

Bristol-Myers Squibb Company (BMY)
Last Price
64.44$
Change
0.73$ (1.15%)
Volume
5.64M

Previous Close 63.71
Open 63.69
Day Range 63.17-64.60
Bid 0.00 x 1.1k
Ask 0.00 x 800
Volume 5.64M
Average Volume 7.98M
Market Cap 135.38B
Beta 0.43
52 Week Range 63.07-81.44
Trailing P/E 18.79
Foward P/E 7.92
Dividend (Yield %) 3.58%
Ex-Dividend Date 2023-04-06

Financial Details


According to Bristol Myers Squibb's financial reports the company's revenue in 2022 were 46.16B an decrease(0%) over the years 2021 revenue that were of 46.38B. In 2022 the company's total earnings were 6.33B while total earnings in 2021 were 6.99B(0%).


Loading ...

Acquisitions List

Date Company Article Price
2022-06-03 Turning Point Therapeutics Turning Point Therapeutics acquired by Bristol Myers Squibb 4.1 B USD
2020-10-05 MyoKardia MyoKardia acquired by Bristol Myers Squibb 13.1 B USD
2020-08-24 Forbius Forbius acquired by Bristol Myers Squibb N/A
2019-11-20 Celgene Celgene acquired by Bristol Myers Squibb N/A
2019-01-03 Celgene Celgene acquired by Bristol Myers Squibb 74 B USD
2017-08-03 IFM Therapeutics IFM Therapeutics acquired by Bristol Myers Squibb N/A
2016-07-05 Cormorant Pharmaceuticals Cormorant Pharmaceuticals acquired by Bristol Myers Squibb N/A
2016-03-23 Padlock Therapeutics Padlock Therapeutics acquired by Bristol Myers Squibb 600 M USD
2015-11-02 Cardioxyl Pharmaceuticals Cardioxyl Pharmaceuticals acquired by Bristol Myers Squibb 2 B USD
2015-02-23 Flexus Biosciences Flexus Biosciences acquired by Bristol Myers Squibb 1.25 B USD

Investors List

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Bristol Myers Squibb

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Post-IPO Equity - Bristol Myers Squibb

aperture-venture-partners_image

Aperture Venture Partners

Aperture Venture Partners investment in Post-IPO Equity - Bristol Myers Squibb

greg-bailey_image

Greg Bailey

Greg Bailey investment in Post-IPO Equity - Bristol Myers Squibb

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Post-IPO Equity - Bristol Myers Squibb

knoll-capital-management_image

Knoll Capital Management

Knoll Capital Management investment in Post-IPO Equity - Bristol Myers Squibb

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Bristol Myers Squibb

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Bristol Myers Squibb

litmore-capital_image

Litmore Capital

Litmore Capital investment in Post-IPO Equity - Bristol Myers Squibb

carl-icahn_image

Carl Icahn

Carl Icahn investment in Post-IPO Equity - Bristol Myers Squibb

Investments List

Date Company Article Money raised
2022-09-08 Autobahn Therapeutics Bristol Myers Squibb investment in Venture Round - Autobahn Therapeutics 32.7 M USD
2022-09-06 ArsenalBio Bristol Myers Squibb investment in Series B - ArsenalBio 220 M USD
2022-08-25 Aktis Oncology Bristol Myers Squibb investment in Series A - Aktis Oncology 84 M USD
2022-07-20 BigHat Biosciences Bristol Myers Squibb investment in Series B - BigHat Biosciences 75 M USD
2022-06-08 Owkin Bristol Myers Squibb investment in Series B - Owkin 50 M USD
2022-06-02 Transition Bio Bristol Myers Squibb investment in Series A - Transition Bio 50 M USD
2022-05-31 Sapience Therapeutics Bristol Myers Squibb investment in Series B - Sapience Therapeutics 41 M USD
2022-05-11 Nuvig Therapeutics Bristol Myers Squibb investment in Series A - Nuvig Therapeutics 47 M USD
2022-04-28 Octant Bio Bristol Myers Squibb investment in Series B - Octant Bio 80 M USD
2022-04-14 Be Biopharma Bristol Myers Squibb investment in Series B - Be Biopharma 130 M USD

Newest Events participated

smit-congress-2019_event_image Participated in SMIT CONGRESS 2019 on 2019-10-10 as exhibitor

clinical-biomarkers-world-cdx_event_image Participated in Clinical Biomarkers & World CDx on 2018-10-04 as sponsor

mixiii-biomed-2018_event_image Participated in Mixiii Biomed 2018 on 2018-05-15 as sponsor

nordic-life-science-days-2017_event_image Participated in Nordic life science Days 2017 on 2017-09-12 as sponsor

fast-company-innovation-festival_event_image Participated in Fast Company Innovation Festival on 2016-11-09 as sponsor

Official Site Inspections

http://www.bms.com Semrush global rank: 106.06 K Semrush visits lastest month: 919.04 K

  • Host name: 165.89.235.99
  • IP address: 165.89.235.99
  • Location: Trenton United States
  • Latitude: 40.2187
  • Longitude: -74.7404
  • Metro Code: 504
  • Timezone: America/New_York
  • Postal: 08629

Loading ...

More informations about "Bristol Myers Squibb" on Search Engine

Bristol Myers Squibb - Wikipedia

The Bristol-Myers Squibb Company (BMS) is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.See details»

Bristol Myers Squibb Products & Medicines

For Medical Information, or to Report Side Effects/Adverse Reactions or to Report Product Quality Complaints – please contact Medical Information. 1 866 463-6267. (toll free) …See details»

Bristol-Myers Squibb Medical Information Online for Canada

Bristol-Myers Squibb Medical Information Online for Canada If you are not a healthcare provider please click here. If you are a healthcare provider please click here. To speak …See details»

Annual Report 2022 - Bristol-Myers Squibb

Annual Report 2022 - Bristol-Myers Squibb. “2022 was an important year for our company, one with significant clinical and regulatory achievements that broadened our portfolio, …See details»

Medical Information for Healthcare Providers - Bristol …

Bristol Myers Squibb provides the following information and resources for U.S. healthcare providers (HCPs) to assist with caring for patients and researching innovative medicines. Our medicines > Quick links U.S. …See details»

Company History Timeline - Bristol Myers Squibb

The clinical center at the Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, is dedicated to the research and treatment of children’s immune system …See details»

BMY | Bristol Myers Squibb Co. Stock Price & News - WSJ

Bristol Myers Squibb Co. BMY (U.S.: NYSE) REAL TIME 10:27 AM EDT 05/31/23 $64.14USD 0.43 0.67% Volume 971,284 65 Day Avg Vol 7,946,820 1 Day Range 63.15 …See details»

Bristol Myers Squibb Receives Positive CHMP Opinion ... - BioSpace

May 26, 2023 About Bristol Myers Squibb. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative …See details»

Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) is First …

May 25, 2023 Further information is available at www.BreyanziREMS.com, or contact Bristol-Myers Squibb at 1-888-423-5436. Hypersensitivity Reactions Allergic reactions …See details»

Bristol Myers Squibb to Present First Results at ASCO and EHA …

May 25, 2023 PRINCETON, N.J., May 25, 2023--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced first results from the Phase 3 COMMANDS …See details»

Home [www.bmsmedinfo.com]

Welcome to Bristol Myers Squibb’s Medical Information Online Our mission is to empower the healthcare community to make informed decisions about our medicines, …See details»

Contact Us - Bristol Myers Squibb

1-800-721-5072 (toll free U.S. only) Medical Information Contact Center 1-800-321-1335 (toll free U.S. only) Mon - Fri 8am - 8pm ET Patient Support That Speaks Your Language …See details»

Bristol Myers Squibb: Investor Relations

Bristol Myers Squibb Submits Application for Abecma®, a CAR T Cell Therapy, for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least …See details»

Bristol-Myers Squibb Company | American company | Britannica

Bristol-Myers Squibb Company, American biopharmaceutical company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. It produces …See details»

Bristol Myers Squibb | LinkedIn

Bristol Myers Squibb | 1,035,011 followers on LinkedIn. We discover, develop and deliver innovative medicines that help patients prevail over serious diseases. | At Bristol Myers …See details»

Bristol Myers (BMY) Reports Pulmonary Fibrosis Study Results

May 23, 2023 In the past 30 days, estimates for Novo Nordisk’s 2023 earnings per share have risen from $4.84 to $5.07. Estimates for 2024 have increased by 34 cents to …See details»

Nivolumab (Opdivo) for Hodgkin Lymphoma | FDA

On May 17, 2016, the U. S. Food and Drug Administration granted accelerated approval to nivolumab (Opdivo, marketed by Bristol-Myers Squibb) for the treatment of patients with classical Hodgkin ...See details»

Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) is First …

May 25, 2023 Bristol Myers Squibb (NYSE: BMY) today announced the first disclosure of results from the primary analysis of the pivotal TRANSCEND CLL 004 study, a Phase …See details»

Is Bristol Myers Squibb a Top Dividend Stock? | The Motley Fool

5 hours ago Bristol Myers Squibb (BMS) ( BMY 0.96%), a multinational pharmaceutical company, has all the hallmarks of a top-shelf dividend stock. The company has boosted …See details»

Bristol Myers Squibb Enters Oversold Territory (BMY) | Nasdaq

May 26, 2023 In trading on Friday, shares of Bristol Myers Squibb Co. (Symbol: BMY) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as …See details»